• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Advantages/Disadvantages of ThinPrep vs Surepath

Quote
Anonymous said:
Um, the new pap test intervals are gonna kill ya both so you were already dead. Guess hologic wants to keep the turd afloat with a bunch of out of vial molecular testing. THat will be the only way to make any money.
Click to expand...

What is the name of the third player in Thin Layer? I remember seeing them a few years ago and predicting they would fail?

Who were they and did they fail??
 








We have tested both techniques and preferred SurePath considering patients' best.

TinPrep: The technique is simpler but expensive. Difficult to find adeno and it is less cells then Surepath. You can not prepare bloody and mucoid specimen by TP.

SurePath: More handwork but cheaper. More cells, no problem with bloody and mucoid specimen. You find more adeno and CIS
 




Anonymous said:
We have tested both techniques and preferred SurePath considering patients' best.

TinPrep: The technique is simpler but expensive. Difficult to find adeno and it is less cells then Surepath. You can not prepare bloody and mucoid specimen by TP.

SurePath: More handwork but cheaper. More cells, no problem with bloody and mucoid specimen. You find more adeno and CIS
Click to expand...

no FDA approved HPV out of vial
limited choices for FDA approved ctng
 
















Hologic got rid of a lot of cytology people as well. they just dumped the responsibilty onto the gen-probe rep in my area. That guy knows NOTHING about cytology. there isnt much future in pap testing anyways. its a dying business.
 












Top Bottom
Back
Quote